Development and Validation of the Systemic Inflammatory Response Index-Based Nomogram for Predicting Short-Term Adverse Events in Patients With Acute Uncomplicated Type B Aortic Intramural Hematoma
- PMID: 39897519
- PMCID: PMC11786605
- DOI: 10.2147/JIR.S496007
Development and Validation of the Systemic Inflammatory Response Index-Based Nomogram for Predicting Short-Term Adverse Events in Patients With Acute Uncomplicated Type B Aortic Intramural Hematoma
Abstract
Purpose: This study aims to develop and validate a nomogram based on the Systemic Inflammatory Response Index (SIRI) to predict short-term aortic-related adverse events (ARAEs) in patients with acute uncomplicated Type B intramural hematoma (IMH).
Patients and methods: We retrospectively analyzed 332 patients diagnosed with acute uncomplicated Type B IMH between April 2018 and April 2024. Patients were categorized into the stable group (N=225) and the exacerbation group (N=107) based on the occurrence of ARAEs within 30-day observation period. SIRI was calculated using neutrophil, monocyte, and lymphocyte counts. ARAEs were defined as death related to aortic disease, and the progression of IMH to aortic dissection or penetrating aortic ulcer. The nomogram was developed incorporating SIRI and other significant clinical variables. The model's performance was evaluated using the area under the curve (AUC), calibration curves, decision curve analysis (DCA), and net reclassification index (NRI).
Results: Among the 332 patients, 217 were male (65.4%), with a mean age of 64.3±9.4 years. Multivariate logistic regression and LASSO regression analyses identified SIRI, anemia, diabetes, maximum diameter of aortic diameter (MDAD), and ulcer like projection (ULP) as independent predictors of ARAEs. Two nomogram models were developed: the Clinical model, including anemia, diabetes, MDAD, and ULP; and the Clinical-SIRI model, incorporating SIRI to the Clinical model. The Clinical-SIRI model demonstrated higher predictive accuracy, with an AUC of 0.788 (95% CI: 0.740-0.831), compared to the Clinical model's AUC of 0.742 (95% CI: 0.691-0.788, P = 0.012). SIRI improved predictive accuracy, as shown by a continuous NRI of 0.521 (95% CI: 0.301-0.743). Calibration curves and DCA further supported the clinical utility of the Clinical-SIRI model.
Conclusion: The SIRI-based nomogram is a valuable prognostic tool for predicting short-term ARAEs in patients with acute uncomplicated Type B IMH.
Keywords: Systemic inflammatory response Index; Type B aortic intramural hematoma; biomarkers; nomogram; prognosis.
Plain language summary
This study introduces a novel nomogram that integrates the Systemic Inflammatory Response Index with clinical variables to enhance the prediction of adverse events in patients with Type B aortic intramural hematoma, a condition marked by highly variable clinical outcomes. The inclusion of this biomarker not only optimizes patient management but also aligns with the growing emphasis on precision in medical interventions.
© 2025 Wang et al.
Conflict of interest statement
All authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures






Similar articles
-
[Development and validation of the MLR-based nomogram for predicting short-term adverse events in patients with acute uncomplicated type B aortic intramural hematoma].Zhonghua Xin Xue Guan Bing Za Zhi. 2025 Feb 24;53(2):128-135. doi: 10.3760/cma.j.cn112148-20241009-00588. Zhonghua Xin Xue Guan Bing Za Zhi. 2025. PMID: 39965847 Chinese.
-
A nomogram prediction model for short-term aortic-related adverse events in patients with acute Stanford type B aortic intramural hematoma: development and validation.Front Cardiovasc Med. 2024 Jul 10;11:1364361. doi: 10.3389/fcvm.2024.1364361. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39049955 Free PMC article.
-
The Value of Different Systemic Inflammatory Response Indicators in the Long-term Prognosis of Type B Aortic Dissection Patients Undergoing Thoracic Endovascular Aortic Repair.J Endovasc Ther. 2024 Dec 20:15266028241305953. doi: 10.1177/15266028241305953. Online ahead of print. J Endovasc Ther. 2024. PMID: 39704096
-
Analysis of Short-Term Clinical Outcomes and Influencing Factors in Patients with Acute Type B Aortic Intramural Hematoma Treated with Optimal Medical Therapy.Int Heart J. 2023 Jul 29;64(4):708-716. doi: 10.1536/ihj.23-023. Epub 2023 Jul 14. Int Heart J. 2023. PMID: 37460317
-
The prognostic value of preoperative systemic inflammatory response index in predicting outcomes of acute type A aortic dissection patients underwent surgical treatment.Front Immunol. 2024 May 10;15:1388109. doi: 10.3389/fimmu.2024.1388109. eCollection 2024. Front Immunol. 2024. PMID: 38799451 Free PMC article.
References
-
- Erbel R, Aboyans V, Boileau C, et al. ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC). Eur Heart J. 2014;35(41):2873–2926. doi:10.1093/eurheartj/ehu281 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous